Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working PartyN: number; CR: complete remission; TCD: T-cell depletion; BM: bone marrow; PBSC: peripheral blood stem cell; MRD: minimal residual disease; CMV: cytomegalovirus; GvHD: graft-versus-host disease.
No takes yet. Share an insight, caveat, or question.
Bazarbachi et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: